Global Structural Heart Devices Market Size, Share, Forecast Report, 2020-2027

Global structural heart devices market is expected to grow at CAGR of 10.4% during the forecast period

Structural heart disease known as a non-coronary anomaly of the heart, therefore not disturbing the blood vessels in the heart. The structural heart diseases refer to cardiac defects which are inherited by birth and can be developed later in life. Common structural heart condition includes atrial septal defect, ventricular septal defect, paravalvular leak, arterial/venous fistulae, patent foramen oval and congenital heart disease.

The rise in the frequency of structural heart diseases and a rise in demand for minimally invasive techniques are factors that drive the growth of the market. However, the high cost of surgeries and stringent government regulations hamper this growth. Equally, rise in emphasis of key players on research and development activities of structural heart devices and increase in demand for rapid and long-lasting procedures among the elderly population are likely to provide profitable breaks for the players in the structural heart devices market.

Advanced products such as sutureless heart valve cost pointedly higher than earlier available products. This double prices of the sutureless device will limit the adoption of the equipment’s, which in turn will restrain the growth of the market.

Segmentation

The global structural heart devices market has been segmented on the basis of type, indication, procedure, and end-user.

On the basis of type, the market has been classified as heart valve devices, occluders and delivery systems, annuloplasty rings, accessories, and other devices. The heart valve devices are segmented into transcatheter heart valves and surgical heart valves. The surgical heart valves are further sub-segmented into tissue heart valves and mechanical heart valves.

On the basis of indication, the market has been classified as valvular heart disease, cardiomyopathy, congenital heart defects, and others. The valvular heart disease is segmented into regurgitation and stenosis.

On the basis of procedure, the market has been classified as Replacement Procedures and repair procedures. The Replacement Procedures is segmented into TAVR procedures and SAVR procedures. The repair procedures are segmented into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures.

On the basis of end-users, the market has been classified as hospitals, ambulatory surgery centers, and others.
Key Players

Some of the key players in the Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK), ST. Jude Medical, Biomerics, Comed BV, JenaValve Technology, Inc., CardioKinetix, Cook Group Incorporated (US), Endologix Inc. (US)., and W. L. Gore & Associates, Inc. (US).

Global Structural Heart Devices Market, by Type

• Heart Valve Devices
• Transcatheter Heart Valves
• Surgical Heart Valves
• Tissue Heart Valves
• Mechanical Heart Valves
• Occluders and Delivery Systems
• Annuloplasty Rings
• Accessories
• Other Devices

Global Structural Heart Devices Market, by Indication

• Valvular Heart Disease
• Regurgitation
• Stenosis
• Cardiomyopathy
• Congenital Heart Defects
• Others

Global Structural Heart Devices Market, by Procedure

• Replacement Procedures
• TAVR Procedures
• SAVR Procedures
• Repair Procedures
• Closure Procedures
• Annuloplasty
• Valvuloplasty
• TMVR Procedures

Global Structural Heart Devices Market, by End User

• Hospitals
• Ambulatory Surgical Centers
• Others